Literature DB >> 18682112

The role of chemokines in virus-associated asthma exacerbations.

Lara E Kallal1, Nicholas W Lukacs.   

Abstract

Asthma is a chronic disease characterized by mast cell activation, mucus hypersecretion, airway obstruction, influx and activation of eosinophils, and generation of a predominant T-helper type 2-based cytokine environment. In individuals with established asthma, acute exacerbations requiring hospitalization result primarily from pulmonary viral infection, such as with influenza, rhinovirus, or respiratory syncytial virus. The mechanism for viral exacerbation of the asthmatic response is unclear, but evidence points to a key role for chemokines, a class of cytokines that are important in leukocyte recruitment, inflammatory cell activation, and T-cell differentiation. In this review, we focus on the chemokines upregulated in acute viral-induced exacerbation and examine their role in promoting the virus-induced pathophysiologic response in asthmatic individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682112     DOI: 10.1007/s11882-008-0084-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  50 in total

1.  Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms.

Authors:  N W Lukacs; K K Tekkanat; A Berlin; C M Hogaboam; A Miller; H Evanoff; P Lincoln; H Maassab
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Attenuation of allergen-induced responses in CCR6-/- mice is dependent upon altered pulmonary T lymphocyte activation.

Authors:  Steven K Lundy; Sergio A Lira; Jetse J Smit; Donald N Cook; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

3.  Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease.

Authors:  K Blease; B Mehrad; T J Standiford; N W Lukacs; S L Kunkel; S W Chensue; B Lu; C J Gerard; C M Hogaboam
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

4.  Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection.

Authors:  Brian D Rudd; Jetse J Smit; Richard A Flavell; Lena Alexopoulou; Matthew A Schaller; Achim Gruber; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

5.  Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness.

Authors:  H Matsuse; A K Behera; M Kumar; H Rabb; R F Lockey; S S Mohapatra
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

6.  Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice.

Authors:  K Blease; B Mehrad; T J Standiford; N W Lukacs; J Gosling; L Boring; I F Charo; S L Kunkel; C M Hogaboam
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity.

Authors:  Sun Ying; Brian O'Connor; Jonathan Ratoff; Qiu Meng; Kirsty Mallett; David Cousins; Douglas Robinson; Guizhen Zhang; Jisheng Zhao; Tak H Lee; Chris Corrigan
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

8.  Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.

Authors:  Loïc Guillot; Ronan Le Goffic; Sarah Bloch; Nicolas Escriou; Shizuo Akira; Michel Chignard; Mustapha Si-Tahar
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

9.  Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.

Authors:  Nathan W Bartlett; Ross P Walton; Michael R Edwards; Juliya Aniscenko; Gaetano Caramori; Jie Zhu; Nicholas Glanville; Katherine J Choy; Patrick Jourdan; Jerome Burnet; Tobias J Tuthill; Michael S Pedrick; Michael J Hurle; Chris Plumpton; Nigel A Sharp; James N Bussell; Dallas M Swallow; Jurgen Schwarze; Bruno Guy; Jeffrey W Almond; Peter K Jeffery; Clare M Lloyd; Alberto Papi; Richard A Killington; David J Rowlands; Edward D Blair; Neil J Clarke; Sebastian L Johnston
Journal:  Nat Med       Date:  2008-02-03       Impact factor: 53.440

10.  Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2.

Authors:  Laura L Koth; Madeleine W Rodriguez; Xin Liu Bernstein; Salina Chan; Xiaozhu Huang; Israel F Charo; Barrett J Rollins; David J Erle
Journal:  Respir Res       Date:  2004-09-15
View more
  7 in total

1.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma.

Authors:  Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

2.  Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells.

Authors:  Zhonghui Yang; Yury A Bochkov; Dennis R Voelker; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 3.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

4.  Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2'-5' oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection.

Authors:  Mizuho Tsutsui-Takeuchi; Hiroko Ushio; Minoru Fukuda; Takahiko Yamada; François Niyonsaba; Ko Okumura; Hideoki Ogawa; Shigaku Ikeda
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

5.  Increased Systemic Cytokine/Chemokine Expression in Asthmatic and Non-asthmatic Patients with Bacterial, Viral or Mixed Lung Infection.

Authors:  M J Giuffrida; N Valero; J Mosquera; A Duran; F Arocha; B Chacín; L M Espina; J Gotera; J Bermudez; A Mavarez; M Alvarez-Mon
Journal:  Scand J Immunol       Date:  2017-04       Impact factor: 3.487

6.  Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses.

Authors:  Yury A Bochkov; William W Busse; Rebecca A Brockman-Schneider; Michael D Evans; Nizar N Jarjour; Christopher McCrae; Anna Miller-Larsson; James E Gern
Journal:  Respir Res       Date:  2013-10-04

7.  Increased cytokine/chemokines in serum from asthmatic and non-asthmatic patients with viral respiratory infection.

Authors:  María J Giuffrida; Nereida Valero; Jesús Mosquera; Melchor Alvarez de Mon; Betulio Chacín; Luz Marina Espina; Jennifer Gotera; John Bermudez; Alibeth Mavarez
Journal:  Influenza Other Respir Viruses       Date:  2013-08-21       Impact factor: 4.380

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.